Krempa C. David's most recent trade in Eton Pharmaceuticals Inc was a trade of 16,977 Common Stock done at an average price of $14.9 . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals Inc | David C. Krempa | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.92 per share. | 12 Jun 2025 | 16,977 | 629,669 (3%) | 0% | 14.9 | 253,297 | Common Stock |
| Eton Pharmaceuticals Inc | David C. Krempa | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.73 per share. | 12 Jun 2025 | 10,223 | 612,646 (3%) | 0% | 14.7 | 150,585 | Common Stock |
| Eton Pharmaceuticals Inc | David C. Krempa | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.77 per share. | 12 Jun 2025 | 6,800 | 622,869 (3%) | 0% | 14.8 | 100,436 | Common Stock |
| Eton Pharmaceuticals Inc | David C. Krempa | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 38,621 | 38,621 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharmaceuticals Inc | David C. Krempa | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 25,876 | 25,876 | - | - | Restricted Stock Units | |
| Eton Pharmaceuticals Inc | David C. Krempa | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 42,088 | 861,374 | - | - | Restricted Stock Units | |
| Eton Pharmaceuticals Inc | Krempa C. David | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 144,677 | 813,430 | - | - | Stock Option (Right to buy) |